Biotech & MedTech News
-
Sixth Wave Commercializes Affinity(TM) System with $3.5M License to AESI
July 14, 2022 (Source) – Sixth Wave Innovations Inc. (CSE: SIXW) (OTCQB: SIXWF) (FSE: AHUH) (“Sixth Wave”, “SIXW” or the…
-
Zentek Announces Appointment of New Board Director
July 5, 2022 (Source) – Zentek Ltd. (“Zentek” or the “Company”) (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company,…
-
Awakn Life Sciences Receives UK State Funding to Identify Optimal Pathway to Market in UK & US for Its Lead Clinical Development Program – Ketamine-Assisted Therapy for Alcohol Use Disorder
Awakn Provides Business Update on Progressing its Lead Program from Phase II b to Phase III July 5,…
-
Sixth Wave AMIPs(TM) Prototype Successfully Detects E. Coli Bacteria in 5 Minutes
July 5, 2022 (Source) – Sixth Wave Innovations Inc. (CSE: SIXW) (OTCQB: SIXWF) (FSE: AHUH) (“Sixth Wave”, “SIXW” or…
-
Sixth Wave Issues Shares for Interest
January 5, 2022 (Source) — Sixth Wave Innovations Inc. (CSE: SIXW) (OTCQB: SIXWF) (FSE: AHUH) (“Sixth Wave” or the…
-
United States Patent & Trademark Office Grants Sixth Wave Innovations Inc. MIPS Patent for Its Unique Method of Metals Extraction and Purification
June 23, 2022 (Source) – Sixth Wave Innovations Inc. (CSE: SIXW) (OTCQB: SIXWF) (FSE: AHUH) (“Sixth Wave”, “SIXW” or the…
-
Hemostemix Announces Closing of UNIT Private Placement
June 22, 2022 (Source) – Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (“Hemostemix” or the “Company”) is pleased to announce…
-
Sixth Wave Ships Affinity(TM) Discovery Unit to Retro/AESI
June 21, 2022 (Source) – Sixth Wave Innovations Inc. (CSE: SIXW) (OTCQB: SIXWF) (FSE: AHUH) (“Sixth Wave”, “SIXW” or the…
-
Awakn Life Sciences to Present in Upcoming June 2022 Conferences
June 17, 2022 (Source) – Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) (‘Awakn’), a revenue-generating…
-
Voyageur Pharmaceuticals Ltd. Announces Closing of Over Subscribed $1Million Private Placement and Issuance of Shares for Debt
June 16, 2022 (Source) – Voyageur Pharmaceuticals Ltd. (TSXV:VM) (OTC:VYYRF) (the “Company” or “Voyageur”) is pleased to announce that, further…
